New insights into the half-of-the-sites reactivity of human aldehyde dehydrogenase 1A1

Proteins: Structure, Function and Bioinformatics

Volumn 81, Issue 8, 2013, Pages 1330-1339

  Yoval Sánchez, Belem ^a   Pardo, Juan Pablo ^b   Rodríguez Zavala, Jose S ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acrolein; ALDH1A1; GFP fusion; Half of the sites reactivity; Presteady state burst; Rate limiting step

Indexed keywords

ACROLEIN; ALDEHYDE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME ISOLATION; ENZYME STRUCTURE; GEL FILTRATION; HUMAN; IONIC STRENGTH; MOLECULAR WEIGHT; MUTANT; MUTATION; OLIGOMERIZATION; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THERMOSTABILITY; WASTE; WILD TYPE;

ACROLEIN; ALDH1A1; GFP-FUSION; HALF-OF-THE-SITES REACTIVITY; PRESTEADY STATE BURST; RATE-LIMITING STEP;

ALDEHYDE DEHYDROGENASE; ENZYME ACTIVATION; GREEN FLUORESCENT PROTEINS; HUMANS; KINETICS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECOMBINANT FUSION PROTEINS;

EID: 84880701665     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24274     Document Type: Article

References (58)

1. Lindahl R.Aldehyde dehydrogenases and their role in carcinogenesis.Crit Rev Biochem Mol Biol 1992;27:283-335.
2. Vasiliou V, Pappa A, Petersen DR.Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.Chem Biol Interact 2000;129:1-19.
3. Hempel J, Bahr-Lindstrom H, Jornvall H.Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme.Eur J Biochem 1984;141:21-35.
4. Yoshida A, Hsu LC, Davé V.Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase.Enzyme 1992;46:239-244.
5. Picklo MJ, Olson SJ, Markesbery WR, Montine TJ.Expression and activities of aldo-keto oxidoreductases in Alzheimer disease.J Neuropathol Exp Neurol 2001;60:686-695.
6. Lassen N, Bateman BB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V.Multiple and additive functions of ALDH3A1 and ALDHA1. Cataract phenotype and ocular oxidative damage in Aldh3a1 (-/-)/ Aldh1a1 (-/-) knock-out mice.J Biol Chem 2007;282:25668-25676.
7. Patel M, Lu L, Zander DS, Sreerama L, Coco D, Moreb JS.ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors.Lung Cancer 2008;59:340-349.
8. Moore SA, Baker HM, Blythe TJ, Kitson KE, Kitson TM, Baker EN.Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases.Structure 1998;6:1541-1551.
9. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D.Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.Science 2008;321:1493-1495.
10. Steinmetz C, Xie P, Weiner H, Hurley TD.Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion.Structure 1997;5:701-711.
11. Yoshida A, Rzhetsky A, Hsu LC, Chang C.Human aldehyde dehydrogenase gene family.Eur J Biochem 1998;251:549-557.
12. Perozich J, Nicholas H, Lindhal R, Hempel J.The big book of aldehyde dehydrogenase sequences: an overview of the extended family.Adv Exp Med Biol 1999;463:45-52.
13. Liu ZJ, Sun YJ, Rose J, Chung YJ, Hsiao CD, Chang WR, Kuo I, Perozich J, Lindahl R, Hempel J, Wang BC.The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold.Nat Struct Biol 1997;4:317-326.
14. Bradbury SL, Jakoby WB.Ordered binding of substrates to yeast aldehyde dehydrogenase.J Biol Chem 1971;246:1834-1840.
15. Bradbury SL, Jakoby WB.Ligand interactions with yeast aldehyde dehydrogenase.J Biol Chem 1971;246:6929-6932.
16. Blackwell LF, Motion RL, MacGibbon AKH, Hardman MJ, Buckley PD.Evidence that the slow conformation change controlling NADH release from the enzyme is rate-limiting during the oxidation of propionaldehyde by aldehyde dehydrogenase.Biochem J 1987;242:803-808.
17. 2+ ions on the individual kinetic steps of human cytosolic and mitochondrial aldehyde dehydrogenases.Biochemistry 2005;44:8022-8029.
18. Feldman R, Weiner H.Horse liver aldehyde dehydrogenase. II. Kinetics and mechanistic implications of the dehydrogenase and esterase activity.J Biol Chem 1972;247:267-272.
19. Weiner H, Hu JH, Sanny CG.Rate-limiting steps for the esterase and dehydrogenase reaction catalyzed by horse liver aldehyde dehydrogenase.J Biol Chem 1976;251:3853-3855.
20. Mann CJ, Weiner H.Differences in the roles of conserved glutamic acid residues in the active site of human class 3 and class 2 aldehyde dehydrogenases.Protein Sci 1999;8:1922-1929.
21. Rodríguez-Zavala JS, Allali-Hassani A, Weiner H.Characterization of E. coli tetrameric aldehyde dehydrogenases with atypical properties compared to other aldehyde dehydrogenases.Protein Sci 2006;15:1387-1396.
22. Yokoyama A, Muramatsu T, Ohmori T, Makuuchi H, Higuchi S, Matsushita S, Yoshino K, Maruyama K, Nakano M, Ishii H.Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2-genotype of Japanese alcoholics.Cancer 1996;77:1986-1199.
23. Sreerma L, Sladek NE.Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Center Institute to screen for potentially useful antitumor agents.Adv Exp Med Biol 1997;414:81-94.
24. Zhai Y, Sperkova Z, Napoli JL.Cellular expression of retinaldehydrogenase types 1 and 2: effects of vitamin A status on testis mRNA.J Cell Physiol 2001;186:220-232.
25. Tanel A, Averill-Bates DA.Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine.J Pharmacol Exp Ther 2007;321:73-83.
26. Wenzl MV, Beretta M, Gorren A, Zeller A, Baral PK, Gruber K, Russwurm M, Koesling D, Schmidt K, Mayer B.Role of the general base Glu-268 in nitroglycerin bioactivation and superoxide formation by aldehyde dehydrogenase-2.J Biol Chem 2009;284:19878-19886.
27. Marcato P, Dean CA, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee P.Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.Stem Cells 2011;29:32-45.
28. Yang K, Feng C, Lip H, Bruce WR, O'brien PJ.Cytotoxic molecular mechanism and cytoprotection by enzymic metabolism for glyceraldehydes, hydroxypyruvate and glycolaldehyde.Chem Biol Interact 2011;191:315-321.
29. Muzio G, Canuto RA, Trombetta A, Maggiora M.Inhibition of cytosolic class 3 aldehyde dehydrogenase by antisense oligonucleotides in rat hepatoma cells.Chem Biol Interact 2001;130-132:219-225.
30. Marchitti SA, Brocker C, Stagos D, Vasiliou V.Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.Expert Opin Drug Metab Toxicol 2008;4:697-720.
31. Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA.Aldehyde dehydrogenases and cell proliferation.Free Radic Biol Med. 2012;52:735-746.
32. Gong D, Zhang Y, Zhang H, Gu H, Jiang Q, Hu S.Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury.Cardiovasc Toxicol 2012;12:350-358.
33. Choudhary S, Xiao T, Vergara LA, Srivastava S, Nees D, Piatigorsky J, Ansari NH.Invest Ophthalmol Vis Sci 2005;46:259-267.
34. Chen Z, Zhang J, Stamler JS.Identification of the enzymatic mechanism of nitroglycerin bioactivation.Proc Natl Acad Sci USA 2002;99:8306-8311.
35. Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto K, Kitagawa K, Nakayama KI, Hess DT, Stamler JS.An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation.Proc Natl Acad Sci USA 2005;102:12159-12164.
36. Beretta M, Gruber K, Kollau A, Russwurm M, Koesling D, Goessler W, Keung WM, Schmidt K, Mayer B.Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases.J Biol Chem 2008;283:17873-17880.
37. Griesberger M, Kollau A, Wölkart G, Wenzl MV, Beretta M, Russwurm M, Koesling D, Schmidt K, Gorren AC, Mayer B.Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase.Mol Pharmacol 2011;79:541-548.
38. Beretta M, Wölkart G, Schernthaner M, Griesberger M, Neubauer R, Schmidt K, Sacherer M, Heinzel FR, Kohlwein SD, Mayer B.Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2.Circ Res 2012;110:385-393.
39. Wenzl MV, Beretta M, Griesberger M, Russwurm M, Koesling D, Schmidt K, Mayer B, Gorren AC.Site-directed mutagenesis of aldehyde dehydrogenase-2 suggests three distinct pathways of nitroglycerin biotransformation.Mol Pharmacol 2011;80:258-266.
40. Sun L, Ferreira JC, Mochly-Rosen D.ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance.Sci Transl Med 2011;3:107-111.
41. Lang BS, Gorren AC, Oberdorfer G, Wenzl MV, Furdui CM, Poole LB, Mayer B, Gruber K.Vascular bioactivation of nitroglycerin by aldehyde dehydrogenase-2 reaction intermediates revealed by crystallography and mass spectrometry.J Biol Chem 2012;287:38124-38134.
42. Tsou PS, Page NA, Lee SG, Fung SM, Keung WM, Fung HL.Differential metabolism of organic nitrates by aldehyde dehydrogenase 1a1 and 2: substrate selectivity, enzyme inactivation, and active cysteine sites.AAPS J 2012;13:548-555.
43. Rodríguez Zavala JS, Weiner H.Structural aspects of aldehyde dehydrogenase that influence dimer-tetramer formation.Biochemistry 2002;41:8229-8237.
44. Lakowicz JR.Principles of fluorescence spectroscopy.New York:Plenum Press;1983. p44.
45. Rodriguez-Zavala JS.Enhancement of coenzyme binding by a single point mutation at the coenzyme binding domain of E. coli lactaldehyde dehydrogenase.Protein Sci 2008;17:563-570.
46. Peitsch MC.Protein modeling by E-mail.Biotechnology 1995;13:658-660.
47. Guex N, Peitsch MC.SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling.Electrophoresis 1997;18:2714-2723.
48. Schwede T, Kopp J, Guex N, Peitsch MC.SWISS-MODEL: anautomated protein homology-modeling server.Nucleic Acids Res 2003;31:3381-3385.
49. Kozakov D, Hall DR, Beglov D, Brenke R, Comeau SR, Shen Y, Li K, Zheng J, Vakili P, Paschalidis IC, Vajda S.Achieving reliability and high accuracy in automated protein docking: Cluspro, PIPER, SDU, and stability analysis in CAPRI rounds 13-19.Proteins 2010;78:3124-3130.
50. Kozakov D, Brenke R, Comeau SR, Vajda S.PIPER: an FFT-based protein docking program with pairwise potentials.Proteins 2006;65:392-406.
51. Rodríguez-Zavala JS, Weiner H.Role of the C-terminal tail on the quaternary structure of aldehyde dehydrogenases.Chem Biol Interact 2001;130-132:151-160.
52. Yoval-Sánchez B, Rodríguez-Zavala JS.Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts.Chem Res Toxicol 2012;25:722-729.
53. Ambroziak W, Kosley LL, Pietruszko R.Human aldehyde dehydrogenase: coenzyme binding studies.Biochemistry 1989;28:5367-5373.
54. Larson HN, Weiner H, Hurley TD.Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant.J Biol Chem 2005;280:30550-30556.
55. Farrés J, Wang X, Takahashi K, Cunningham SJ, Wang TT, Weiner, H.Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase.J Biol Chem 1994;269:13854-13860.
56. Chalfie M, Kain SR. Green fluorescent protein: properties, applications and protocols (Methods of Biochemical Analysis, Vol.47).New York:John Wiley & Sons;2005. pp48-50.
57. Zahler WL, Cleland WW.A specific and sensitive assay for disulfides.J Biol Chem 1968;243:716-719.
58. Snow ET.Metal carcinogenesis: mechanistic implications.Pharmacol Ther 1992;53:31-65.